Evidence map›Paper›PMID 33655083›Full record

ArticleHeliyon2021

Covid-19 in Cartagena and the Bolívar Department, Colombia. Current status, perspectives and challenges until the arrival of the vaccine.

Fabián Espitia-Almeida, Ramiro Pereira-Lentino, Juan Quintero-Soto, Doris Gómez-Camargo

Abstract read
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fabián Espitia-AlmeidaUNIMOL Research Group, School of Medicine, University of Cartagena. Cartagena de Indias 130001, Colombia.
Ramiro Pereira-LentinoDepartmental Laboratory of Public Health of Bolivar, Cartagena de Indias 130001, Colombia.
Juan Quintero-SotoUNIMOL Research Group, School of Medicine, University of Cartagena. Cartagena de Indias 130001, Colombia.
Doris Gómez-CamargoUNIMOL Research Group, School of Medicine, University of Cartagena. Cartagena de Indias 130001, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, caused by SARS-CoV-2, a new coronavirus, was first observed in Wuhan (China) in November 2019. In a short time, SARS-CoV-2 spread across the world, creating a pandemic. There is a need to know the current situation of each country and region and to generate strategies to contain and mitigate the impact on global health and the economy. To control COVID-19 in Cartagena and the Department of Bolívar, Colombia, a strategic network involving public health entities and higher education institutions has emerged. The network has been in place for six months, and 77,122 subjects have been tested in Cartagena and Bolívar Department, of whom 8,260 (10.71%) tested positive (RT-qPCR). Of those who tested positive, 51.4% were male (

Indexed as

COVID-19PandemicSARS-CoV-2SurveillanceVaccine

Identifiers

PMID33655083
PMCPMC7894252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.